FM
GILD icon

Family Management’s Gilead Sciences GILD Stock Holding History

Family Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Sell
29,547
-10
-0% -$1.32K 0.38% 57
2026
Q1 		$4.12M Sell
29,557
-26,932
-48% -$3.77M 0.49% 48
2025
Q4 		$6.93M Buy
56,489
+2,532
+5% +$308K 0.88% 28
2025
Q3 		$5.99M Buy
53,957
+2,781
+5% +$316K 0.82% 33
2025
Q2 		$5.67M Buy
51,176
+26,046
+104% +$2.77M 0.85% 32
2025
Q1 		$2.82M Buy
+25,130
New +$2.59M 0.46% 59
2017
Q1 		– Sell
-55,991
Closed -$4.01M – 73
2016
Q4 		$4.01M Sell
55,991
-8,260
-13% -$614K 2.74% 16
2016
Q3 		$5.08M Sell
64,251
-1,670
-3% -$136K 2.87% 13
2016
Q2 		$5.5M Sell
65,921
-1,240
-2% -$110K 3.11% 10
2016
Q1 		$6.17M Sell
67,161
-242
-0.4% -$21.8K 4% 10
2015
Q4 		$6.82M Buy
67,403
+45
+0.1% +$4.68K 3.52% 11
2015
Q3 		$6.61M Buy
67,358
+10,475
+18% +$1.16M 2.92% 11
2015
Q2 		$6.66M Buy
56,883
+23,083
+68% +$2.52M 2.75% 11
2015
Q1 		$3.32M Buy
33,800
+14,150
+72% +$1.44M 1.53% 28
2014
Q4 		$1.85M Buy
+19,650
New +$2.03M 0.84% 40

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Family Management's GILD Position: Q2 2026 in Review

Family Management reduced its Gilead Sciences (GILD) stake by 0.03% in Q2 2026, selling an estimated $1.32K and leaving 29,547 shares worth $3.73M. The position accounts for 0.38% of the portfolio, ranked #57.

Family Management first reported a position in GILD in Q4 2014 and has held it in 15 quarters since. The position peaked at $6.93M in Q4 2025. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Family Management held 29,547 shares of Gilead Sciences worth $3.73M as of Q2 2026.
  • Family Management sold 10 Gilead Sciences shares in Q2 2026, an estimated $1.32K.
  • Gilead Sciences made up 0.38% of Family Management's portfolio in Q2 2026, its #57 holding.
  • Family Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 15 quarters since.
  • Family Management's Gilead Sciences position peaked at $6.93M in Q4 2025.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Family Management's 13F filing for Q2 2026, filed 14 Aug 2026.